Christine Chomienne Selected Research

Pipobroman (Vercyte)

10/2011	Treatment of polycythemia vera with hydroxyurea and pipobroman: final results of a randomized trial initiated in 1980.
6/2006	Long-term incidence of hematological evolution in three French prospective studies of hydroxyurea and pipobroman in polycythemia vera and essential thrombocythemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Christine Chomienne Research Topics

Disease

22	Leukemia 10/2021 - 04/2002
19	Acute Promyelocytic Leukemia 01/2020 - 06/2003
17	Neoplasms (Cancer) 01/2021 - 11/2003
11	Polycythemia Vera 01/2022 - 05/2005
8	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 07/2017 - 02/2004
6	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 09/2021 - 07/2004
5	Myeloid Leukemia (Leukemia, Myelocytic) 01/2009 - 01/2002
4	Hematologic Neoplasms (Hematological Malignancy) 10/2021 - 01/2019
3	Polycythemia (Erythrocytosis) 01/2022 - 05/2011
2	Anemia 01/2021 - 07/2004
2	Primary Myelofibrosis (Myelosclerosis) 10/2017 - 10/2011
2	Essential Thrombocythemia 12/2015 - 06/2006
2	Thyroid Neoplasms (Thyroid Cancer) 02/2015 - 01/2012
2	Genomic Instability 01/2015 - 09/2007
2	Gaucher Disease (Gaucher's Disease) 01/2013 - 01/2012
2	Hypersensitivity (Allergy) 02/2010 - 06/2006
2	Infections 08/2009 - 01/2005
2	Hypereosinophilic Syndrome (Loeffler Endocarditis) 02/2008 - 06/2006
2	Genetic Translocation (Chromosomal Translocation) 10/2005 - 04/2005
2	Autosomal Recessive 3 Severe Congenital Neutropenia 01/2005 - 06/2004
2	Cyclic neutropenia 01/2005 - 06/2004
1	Spinocerebellar Ataxias (Spinocerebellar Ataxia) 09/2021
1	Hematologic Diseases (Blood Diseases) 01/2019
1	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 01/2019
1	Sarcoma (Soft Tissue Sarcoma) 10/2018
1	Inflammation (Inflammations) 09/2018
1	Fibrosis (Cirrhosis) 10/2017
1	Thrombocytosis (Thrombocythemia) 10/2016
1	Myeloproliferative Disorders (Myeloproliferative Disorder) 09/2015
1	Breast Neoplasms (Breast Cancer) 08/2015
1	Autoimmune Diseases (Autoimmune Disease) 06/2015
1	Carcinogenesis 01/2015
1	Lung Neoplasms (Lung Cancer) 11/2013
1	Adenocarcinoma of Lung 11/2013

Drug/Important Bio-Agent (IBA)

15	Tretinoin (Retinoic Acid)FDA LinkGeneric 10/2015 - 06/2003
8	Proteins (Proteins, Gene)FDA Link 09/2018 - 10/2004
6	DNA (Deoxyribonucleic Acid)IBA 10/2015 - 11/2003
5	EnzymesIBA 10/2021 - 06/2015
5	Biomarkers (Surrogate Marker)IBA 04/2020 - 01/2009
4	VaccinesIBA 01/2020 - 11/2003
4	Retinoic Acid Receptor alphaIBA 10/2015 - 11/2003
3	Etoposide (VP 16)FDA LinkGeneric 10/2021 - 01/2019
3	Interferon-alpha (Interferon Alfa)IBA 04/2020 - 10/2008
3	Peptides (Polypeptides)IBA 01/2020 - 10/2005
3	InterferonsIBA 01/2018 - 09/2006
3	Arsenic Trioxide (Trisenox)FDA Link 01/2018 - 06/2003
3	AnthracyclinesIBA 07/2015 - 12/2006
3	CalciumIBA 11/2013 - 10/2004
3	Monoclonal AntibodiesIBA 03/2012 - 01/2002
3	RetinoidsIBA 01/2012 - 06/2006
2	Erythropoietin FDA Link 01/2022 - 07/2004
2	1,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA 10/2021 - 09/2007
2	Benzene (Benzole)IBA 01/2021 - 01/2019
2	Transcription Factors (Transcription Factor)IBA 01/2021 - 02/2004
2	RNA (Ribonucleic Acid)IBA 01/2020 - 01/2017
2	Type II DNA Topoisomerases (Topoisomerase II)IBA 01/2019 - 04/2005
2	quinone (benzoquinone)IBA 01/2019 - 01/2019
2	CalreticulinIBA 01/2018 - 01/2017
2	DNA VaccinesIBA 10/2015 - 11/2003
2	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 09/2015 - 06/2006
2	Oncogene Proteins (Oncogene Protein)IBA 09/2015 - 04/2005
2	Mitoxantrone (Novantrone)FDA LinkGeneric 07/2015 - 04/2005
2	A-Form DNA (A-DNA)IBA 02/2013 - 11/2003
2	Glucosylceramidase (Glucocerebrosidase)IBA 01/2013 - 01/2012
2	Hydroxyurea (Hydrea)FDA LinkGeneric 10/2011 - 06/2006
2	Pipobroman (Vercyte)FDA Link 10/2011 - 06/2006
2	Tyrosine Kinase InhibitorsIBA 02/2008 - 11/2003
2	Imatinib Mesylate (Gleevec)FDA Link 02/2008 - 11/2003
2	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2005 - 07/2004
1	ABT-737IBA 09/2021
1	Environmental Pollutants (Pollutants, Environmental)IBA 01/2021
1	Histone MethyltransferasesIBA 01/2021
1	CarcinogensIBA 01/2021
1	indium oxineIBA 01/2019
1	Janus KinasesIBA 01/2019
1	Thrombopoietin ReceptorsIBA 01/2019
1	von Willebrand FactorIBA 09/2018
1	P-SelectinIBA 09/2018
1	Membrane Proteins (Integral Membrane Proteins)IBA 01/2018
1	CalnexinIBA 01/2018
1	alovudineIBA 10/2017
1	Azacitidine (5 Azacytidine)FDA Link 07/2017
1	Nonsense Codon (Nonsense Mutation)IBA 10/2016
1	2-aminoethyl diphenylborinateIBA 08/2015
1	6-pyruvoyltetrahydropterin synthase (PTPS)IBA 06/2015
1	Protein Tyrosine PhosphatasesIBA 06/2015
1	Thyroglobulin FDA Link 02/2015
1	EuchromatinIBA 01/2015
1	ChromatinIBA 01/2015
1	HeterochromatinIBA 01/2015
1	LigandsIBA 01/2012
1	Bexarotene (LGD1069)FDA Link 01/2012
1	Dihydrotachysterol (AT 10)IBA 10/2011

Therapy/Procedure

19	Therapeutics 10/2021 - 11/2003
3	Immunotherapy 10/2015 - 10/2005
2	Drug Therapy (Chemotherapy) 07/2017 - 07/2013
2	Transplantation 07/2004 - 05/2003
1	Hemodilution 01/2021
1	Genomic Medicine 01/2020
1	Chemoradiotherapy 07/2015